Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors

Dengue virus is an increasingly global pathogen. One of the promising targets for antiviral drug discovery against dengue and related flaviviruses such as West Nile virus is the viral serine protease NS2B-NS3. We here report the synthesis and in vitro characterization of potent peptidic inhibitors o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weigel, Lena (VerfasserIn) , Nitsche, Christoph (VerfasserIn) , Graf, Dominik Korbinian (VerfasserIn) , Bartenschlager, Ralf (VerfasserIn) , Klein, Christian D. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 14, 2015
In: Journal of medicinal chemistry
Year: 2015, Jahrgang: 58, Heft: 19, Pages: 7719-7733
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.5b00612
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acs.jmedchem.5b00612
Volltext
Verfasserangaben:Lena F. Weigel, Christoph Nitsche, Dominik Graf, Ralf Bartenschlager, and Christian D. Klein
Beschreibung
Zusammenfassung:Dengue virus is an increasingly global pathogen. One of the promising targets for antiviral drug discovery against dengue and related flaviviruses such as West Nile virus is the viral serine protease NS2B-NS3. We here report the synthesis and in vitro characterization of potent peptidic inhibitors of dengue virus protease that incorporate phenylalanine and phenylglycine derivatives as arginine-mimicking groups with modulated basicity. The most promising compounds were (4-amidino)-l-phenylalanine-containing inhibitors, which reached nanomolar affinities against dengue virus protease. The type and position of the substituents on the phenylglycine and phenylalanine side chains has a significant effect on the inhibitory activity against dengue virus protease and selectivity against other proteases. In addition, the non-natural, basic amino acids described here may have relevance for the development of other peptidic and peptidomimetic drugs such as inhibitors of the blood clotting cascade.
Beschreibung:Gesehen am 29.06.2020
Beschreibung:Online Resource
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.5b00612